VTAK (Catheter Precision) Forward Dividend Yield %: 0.00% (As of Jul. 05, 2026)


VTAK Catheter Precision Inc VTAK
23 GF Score
Price $0.79
GF Value $1.71
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Catheter Precision Forward Dividend Yield %?

Catheter Precision VTAK -8.67% 23 Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus rates VTAK with a GF Score™ of 23/100 and a GF Value™ of $1.71 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Catheter Precision ranks worse than 317460% on this metric.

As of today (2026-07-05), the Forward Annual Dividend Yield of Catheter Precision is 0.00%.

As of today (2026-07-05), the Trailing Annual Dividend Yield of Catheter Precision is 0.00%.

VTAK's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.03
* Ranked among companies with meaningful Forward Dividend Yield % only.

Catheter Precision's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Catheter Precision  (AMEX:VTAK) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Catheter Precision Forward Dividend Yield % Related Terms


VTAK vs ALURD, BJDX, AMIX: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Catheter Precision's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catheter Precision Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Catheter Precision's Forward Dividend Yield % falls into.


VTAK
23GF Score
Catheter Precision Inc VTAK
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Catheter Precision Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Catheter Precision (VTAK) has a Forward Dividend Yield % of 0.00% as of Jul. 05, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Catheter Precision and its competitors. According to the industry distribution chart, Catheter Precision ranks #999999 out of 315 companies in the Medical Devices & Instruments industry.
Is Catheter Precision's Forward Dividend Yield % too high?
Catheter Precision's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Catheter Precision ranks #999999 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Catheter Precision has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Forward Dividend Yield % compare to ALURD and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #999999 out of 315 companies for Forward Dividend Yield %. This places Catheter Precision in the lower half of its industry. The industry median Forward Dividend Yield % is 2.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.03, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.71, compared to a current price of $0.79 — trading 53.8% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Catheter Precision (VTAK), the current Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (VTAK) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of $0.79 is trading 53.8% below its estimated GF Value™ of $1.71. GuruFocus considers Catheter Precision to be Possible Value Trap.

Key valuation signals for VTAK:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: $1.71 vs. price of $0.79 (53.8% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Catheter Precision Business Description

Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for VTAK

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.79
Price
$1.71
GF Value